🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Irene Y. Cheung

ORCID: 0000-0002-1427-514X

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission”.

A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3427

N/A

0.317DataRank · unranked

7 citations

Shakeel Modak, Audrey Mauguen, Ellen M. Basu, Kim Kramer, Stephen S. Roberts +3 more

T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002509

N/A

0DataRank · unranked

18 citations

Mallika Vadlamudi, Madelyn Espinosa‐Cotton, Hoa Tran, Yi Feng, Hong-Fen Guo +4 more

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine

Vaccines(2024)10.3390/vaccines12060587

N/A

0DataRank · unranked

2 citations

Audrey Mauguen, Shakeel Modak, Ellen M. Basu, Yi Feng, Brian H. Kushner +2 more